Zdrowie i gospodarka · 04/04/2016

FDA Amends Lesser Administrative Actions for Noncompliance with IRB Regulations

The FDA is clarifying lesser administrative actions that can be taken against Institutional Review Boards (IRBs) that fail to comply with FDA's IRB regulations, including withholding study approvals, stopping new subject enrollment, and terminating ongoing studies, to ensure clarity and accuracy in the regulations.